Advertisement

Syndrome d’hyperstimulation ovarienne

  • M. Germond
  • M.-C. Gaillard
  • A. Senn
Chapter
  • 6 Downloads
Part of the Archives of Gynecology and Obstetrics book series (AGYO)

Résumé

Le syndrome d’hyperstimulation ovarienne (SHO) peut être défini comme étant une pathologie iatrogène secondaire à l’administration de principes actifs administrés en vue d’obtenir une maturation folliculaire et une ovulation. L’étiologie, la Physiopathologie, les moyen diagnostiques ainsi que les mesures thérapeutiques à disposition sont discutés. Un modèle théorique, basé sur l’analyse de données cliniques, nous permet d’évaluer les critères qui nous autoriseront à déterminer prospectivement le risque potentiel de voir se développer cette pathologie.

Summary

The ovarian hyperstimulation syndrom (SHO) can be defined as an iatrogenic pathology induced by active substances administered for controlling follicular maturation and ovulation. The etiology, the physiopathology, the diagnostic and therapeutic methods available are discussed. A theoretical model, based on clinical data, allows identification of a set of criteria which should help determining prospectively the chances of development of such a pathology.

Bibliographie

  1. 1.
    Blankstein J, Bloom S, Lunenfeld B (1986) Pathogénie et traitement des hyperstimulations ovariennes sévères. In: Buvat J, Bringer J (eds) Induction et stimulation de l’ovulation. Doin, Paris, p 163Google Scholar
  2. 2.
    Bettendorf G, Lindner Ch (1987) The ovarian hyperStimulation syndrome. Horm Metab Res 19: 519–522PubMedCrossRefGoogle Scholar
  3. 3.
    Robertson AL, Khairallah PhA (1972) Effects of angiotensin II and some analogues on vascular permeability in the rabit. Circ Res 31: 923–931PubMedCrossRefGoogle Scholar
  4. 4.
    Kiatner RW (1965) Induction of ovulation with clomiphene citrate (Clomid). Obstet Gynecol 20: 873–900Google Scholar
  5. 5.
    Kirshon B, Doody MC, Cotton DB, Gibons W (1988) Management of ovarian hyperstimulation syndrome with chlorpheniramine maleate, mannitol, and invasive hemodynamic monitoring. Obstet Gynecol 71: 485–487PubMedGoogle Scholar
  6. 6.
    Klein J (1963) Delayed appearance and rupture of lutein cysts with hydatiform mole. Obstet Gynecol 21: 31–32Google Scholar
  7. 7.
    Lindner Ch, Braendle W, Lichtenberg V, Bettendorf G (1988) Analysis of 500 GnRH-agonists/ HMG cycles for in vivo fertilization, IVF and GIFT. In: Proceedings of the 4th ESHRE meeting, Barcelona, p 2Google Scholar
  8. 8.
    Lunenfeld B, Insler V, Rabau E (1969) Induction de l’ovulation par les gonadotrophines. In: Moricard R, Ferin J (eds) L’Ovulation. Masson, Paris, p 291Google Scholar
  9. 9.
    Pride SM, Basil Ho, Yuen Moon YS (1984) Clinical, endocrinologic, and intraovarian prostaglandin F response to H-1 receptor blockade in the ovarian hyperstimulation syndrome: studies in the rabit model. Am J Obstet Gynecol 148: 670–675PubMedCrossRefGoogle Scholar
  10. 10.
    Robertson AL, Khairallah PhA (1972) Effects of angiotensin II and some analogues on vascular permeability in the rabit. Circ Res 31: 923–931PubMedCrossRefGoogle Scholar
  11. 11.
    Schenker JG, Polishuk WZ (1967) Ascites in a case of twin pregnancy. J Obstet Gynaecol Br Commonwelth 74: 451–453CrossRefGoogle Scholar
  12. 12.
    Schenker JG, Weinstein D (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 30: 255–268PubMedGoogle Scholar
  13. 13.
    Van der Merwe, Michell WL, Kruger TF (1988) Severe ovarian hyperstimulation after follicular aspiration. S Afr Med J 73: 426–427PubMedGoogle Scholar
  14. 14.
    Vervest HAM, Coelingh-Bennink HJT (1985) Hyperstimulation with GnRH. In: Procedings of the 3rd Ferring Symposium, Noordwijk, Septembre, 11–13, pp 201–206Google Scholar
  15. 15.
    Wang Chun Fu, Gemzell C (1980) The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril 33: 479–486PubMedGoogle Scholar
  16. 16.
    Fernandez LA, Twlicker J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105: 141–145PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • M. Germond
    • 1
  • M.-C. Gaillard
    • 1
  • A. Senn
    • 1
  1. 1.Départment de Gynécologie et d’ObstétriqueCHUVLausanneSwitzerland

Personalised recommendations